Session information—October 9, 2025

Topic

The microbiome and treatment efficacy: Implications of checkpoint inhibitors and antibacterial therapy

Date and time

October 9, 2025, at 16:00 (CEST)

Learning objectives for the webinar:

• Understand the role of the microbiome in modulating the efficacy of checkpoint inhibitors in cancer therapy, including the mechanisms by which gut bacteria influence immune responses.
• Explore the impact of antibacterial therapy on the microbiome and its subsequent effects on the effectiveness of checkpoint inhibitors, with a focus on clinical outcomes and potential strategies to mitigate negative interactions.

Speaker

Dr. Marco Villanueva Reza, National Institute of Respiratory Diseases, Mexico

Dr. Marco Villanueva Reza is originally from Mexico City. He earned his medical degree from the Mexican Faculty of Medicine La Salle and subsequently specialized in Internal Medicine at Medica Sur Hospital. He then completed a fellowship in Infectious Diseases at the National Institute of Medical Sciences and Nutrition Salvador Zubirán. Additionally, he obtained a master’s degree in Infectious Diseases from the London School of Hygiene and Tropical Medicine. Currently, he serves as the Coordinator of Prevention and Infection Control at the National Institute of Respiratory Diseases, where he focuses on infections in oncologic patients and fungal infections.